Thyroid Cancer Gene Mutation Detection Kit (High Throughput Sequencing)

Primary DI

06972665700318

Basic UDI-DI Code

B-06972665700318

Reference

Lotus NL B.V. Koningin Julianaplein 10, 1e Verd, 2595AA, The Hague, Netherlands. E-mail:[email protected]

Device Types

Single use Sterilization

Regulation

Eu Ivdd

Classification

Eu Ivd General

Status

On The Market

Manufacturer

XIAMEN SPACEGEN CO.,LTD.

16 tests / kit,This kit takes the nucleic acid extracted from fine needle puncture sample or tissue sample of thyroid cancer (TC) as the test sample, including 16 genes on the DNA and 87 genes (209 fusion forms) on the RNA. See Annex Table 1 for the specific gene list. It covers the key pathogenic genes of thyroid cancer, including single nucleotide variation, small fragment insertion / deletion, and gene fusion mutation types. The test results are helpful to evaluate the molecular characteristics of patients with thyroid cancer so as to provide clinical reference, improve the accuracy of benign and malignant judgment of thyroid cancer, optimize treatment plan, accurately guide medication and assist genetic screening.

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).